Abstract
Over the last few years, sildenafil is increasingly being used in the neonatal ICU for a variety of indications. The use is even more so in the developing world due to the limited availability of nitric oxide and extracorporeal membrane oxygenation (ECMO). There are still no clear cut guidelines for its use. At present the drug appears relatively safe and effective when other treatment options have been optimized. However, the use of sildenafil must be monitored and reported. Due to its easy availability and ease of administration we must guard against its inappropriate use.
Similar content being viewed by others
References
Kumar S. Indian doctor in protest after using Viagra to save “blue babies”. BMJ. 2002;325:181.
Oliver J, Webb DJ, Patole S, Travadi J. Sildenafil for “blue babies”. BMJ. 2002;325:1174.
Michelakis E, Tymchak W, Lien D, Webster L, Hashimoto K, Archer S. Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation. 2002;105:2398–403.
Shekerdemian LS, Ravn HB, Penny DJ. Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med. 2002;165:1098–102.
Baquero H, Soliz A, Neira F, Venega M, Sola A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics. 2006;117:1077–1083.
Macrae DJ. Drug therapy in PPHN. Semin Neonatol. 1997;2:49–58.
Namachivayam P, Theilen U, Butt W, Cooper S, Penny D, Shekerdemian L. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med. 2006;174:1042–1047.
Leibovitch I, Matok I, Paret G. Therapeutic applications of sildenafil citrate in management of pediatric pulmonary hypertension. Drugs. 2007;67:57–73.
Ahsman MJ, Witjes BC, Wildschut ED, Sluiter I, Vulto AG, Tibboel D, et al. Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube. Arch Dis Child Fetal Neonatal Ed. 2010;95:F109–114.
Saxena A, Juneja R, Ramakrishnan S. Drug therapy of cardiac diseases in children.Working Group on Management of Congenital Heart Diseases in India. Indian Pediatr. 2009;46:310–338.
Mourani PM, Sontag MK, Ivy DD Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr. 2009;154:379–384.
Galie N, Ghofrani HA, Torbici A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148–2157.
Shekerdemian LS, Ravn HB, Penny DJ. Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome. Pediatr Res. 2004;55:413–418.
Marsh CS, Marden B, Newsom R. Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension. Br J Ophthalmol. 2004;88:306–307.
Gamboa D, Robbins D, Saba Z. Bleeding after circumcision in a newborn receiving Sildenafil. Clin Pediatr (Phila). 2007;46:842–843.
Shah P, Ohlsson A. Sildenafil for pulmonary hypertension in neonates (review). Cochrane Database Syst Rev. 2007;3:CD005494.
Hunter L, Richens T, Davis C, Walker G, Simpson JH, et al. Sildenafil use in congenital diaphragmatic hernia. Arch Dis Child Fetal Neonatal Ed. 2009;94:F467.
Carroll WD, Dhillon R. Sildenafil as a treatment for pulmonary hypertension. Arch Dis Child. 2003;88:827–828.
Raja SG, Macarthur KJ, Pollock JC. Is Sildenafil effective for treating pulmonary hypertension after pediatric heart surgery? Interact Cardiovasc Thorac Surg. 2006;5:52–54.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Malik, M., Nagpal, R. Emerging role of sildenafil in neonatology. Indian Pediatr 48, 11–13 (2011). https://doi.org/10.1007/s13312-011-0012-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-011-0012-2